<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7130072/results/search/country/results.xml">
  <result pre="for medications. •Encourage and fund nonprofit generic drug manufacturing in" exact="the United States." post="•Prohibit deductibles and rebates for COVID-19–specific drugs. •Increase the"/>
  <result pre="medications. •Encourage and fund nonprofit generic drug manufacturing in the" exact="United States." post="•Prohibit deductibles and rebates for COVID-19–specific drugs. •Increase the"/>
  <result pre="only one or two FDA-approved versions available for sale in" exact="the United States." post="In contrast, in some countries in Europe and in"/>
  <result pre="one or two FDA-approved versions available for sale in the" exact="United States." post="In contrast, in some countries in Europe and in"/>
  <result pre="by an established manufacturer hitherto not authorized to sell in" exact="the United States." post="Second, the federal government must work with major brand"/>
  <result pre="an established manufacturer hitherto not authorized to sell in the" exact="United States." post="Second, the federal government must work with major brand"/>
  <result pre="we must encourage and fund nonprofit generic drug manufacturing in" exact="the United States." post="Civica Rx, for instance, was founded with the goal"/>
  <result pre="must encourage and fund nonprofit generic drug manufacturing in the" exact="United States." post="Civica Rx, for instance, was founded with the goal"/>
  <result pre="companies despite critical need. Fourth, in addition to negotiating with" exact="China" post="to increase supply, the United States must consider increasing"/>
  <result pre="Fourth, in addition to negotiating with China to increase supply," exact="the United States" post="must consider increasing the domestic manufacture of active pharmaceutical"/>
  <result pre="in addition to negotiating with China to increase supply, the" exact="United States" post="must consider increasing the domestic manufacture of active pharmaceutical"/>
  <result pre="of active pharmaceutical ingredients.10 Since factories closed in China, and" exact="India" post="shut down exports of medications, we have been under"/>
  <result pre="reminds us of the importance of having backup manufacturing within" exact="the United States," post="supported by taxpayer funds if needed. Finally, any state"/>
  <result pre="us of the importance of having backup manufacturing within the" exact="United States," post="supported by taxpayer funds if needed. Finally, any state"/>
  <result pre="that can increase the prices of COVID-19 related drugs in" exact="the United States" post="are pharmacy benefit managers (PBMs), who normally act as"/>
  <result pre="can increase the prices of COVID-19 related drugs in the" exact="United States" post="are pharmacy benefit managers (PBMs), who normally act as"/>
  <result pre="7ByrnesH.HarringtonJ.Prescription Unfilled? These 30 Drugs Are in Short Supply in" exact="the US" post="Right Now. 2020https://www.usatoday.com/story/money/2020/03/10/fda-shortage-30-drugs-currently-in-short-supply-in-the-us/111402408/ 8collab: US Food and Drug AdministrationGeneric"/>
  <result pre="Disrupt the U.S. Drug Supply. 2020https://www.cfr.org/in-brief/coronavirus-disrupt-us-drug-supply-shortages-fda 11PalmerE.Chinese APIs Flowing But" exact="India" post="Ban Hinders U.S. Approval of Hydroxychloroquine. 2020https://www.fiercepharma.com/manufacturing/chinese-apis-flowing-but-indian-ban-hinders-u-s-approval-hydroxychloroquine 12PalmerE.How Much"/>
  <result pre="Approval of Hydroxychloroquine. 2020https://www.fiercepharma.com/manufacturing/chinese-apis-flowing-but-indian-ban-hinders-u-s-approval-hydroxychloroquine 12PalmerE.How Much Does U.S. Rely on" exact="China" post="for Drugs? FDA Simply Doesn't Know. 2020https://www.fiercepharma.com/manufacturing/how-much-does-u-s-rely-china-for-drugs-fda-simply-doesn-t-know 13RajkumarS.V.The high"/>
 </snippets>
</snippetsTree>
